Patient Portal

Clifford G. Robinson, MD

Assistant Professor, Radiation Oncology
Chief of Service, Stereotactic Body Radiation Therapy (SBRT)

Specialty Areas

Brain Tumors
Gamma Knife
Thoracic Oncology
Neuro Oncology
Radiation Oncology

Board Certifications

Radiation Oncology

Hospital Affiliations

Barnes-Jewish Hospital
Barnes-Jewish West County Hospital

Areas of Clinical Interest

Lung cancer, esophageal cancer, brain tumor, spine tumor, gamma knife, stereotactic body radiation therapy

  • Location(s)
  • Education
  • Publication & Research
  • Financial Disclosures

Location(s)

Location(s)

Center for Advanced Medicine

4921 Parkview Place
St. Louis, MO 63110

Floor: LL
Office Phone: 314-747-7236
Fax: 314-362-7769

Barnes-Jewish West County Hospital
Medical Building Two

10 Barnes West Drive
Creve Coeur, MO 63141

Office Phone: 314-996-3335
Fax: 314-996 3338

Education

Education

Medical Degree: Case Western Reserve University School of Medicine, Cleveland, Ohio 2004
Residency : Radiation Oncology, Cleveland Clinic, Cleveland, OH 2009
Chief Resident: Radiation Oncology, Cleveland Clinic, Cleveland, OH 2008
B.S. (Molecular Biology): University of Pittsburgh, Pittsburgh, PA 2000

Publication & Research

Publication & Research

The Metastatic Spine Disease Multidisciplinary Working Group Algorithms.
Wallace AN, Robinson CG, Meyer J, Tran ND, Gangi A, Callstrom MR, Chao ST, Van Tine BA, Morris JM, Bruel BM, Long J, Timmerman RD, Buchowski JM, Jennings JW
Oncologist. 2019 Mar; 24(3)424. doi: 10.1634/theoncologist.2015-0085err.

PMID:
    30867318
    [PubMed - in process]
Related citations


Treatment of T3N0 non-small cell lung cancer with chest wall invasion using stereotactic body radiotherapy.
Kennedy WR, Gabani P, Nikitas J, Samson PP, Robinson CG, Bradley JD, Roach MC
Clin Transl Radiat Oncol. 2019 May; 161-6. doi: 10.1016/j.ctro.2019.02.004.

PMID:
    30859139
    [PubMed]
Related citations


Lessons Learned From the First Human Low-Field MRI Guided Radiation Therapy of the Heart in the Presence of an Implantable Cardiac Defibrillator.
Gach HM, Green OL, Cuculich PS, Wittland EJ, Marko A, Luchtefeld ME, Entwistle JM, Yang D, Wilber DJ, Mutic S, Robinson CG
Pract Radiat Oncol. 2019 Feb 18; pii: S1879-8500(19)30050-5. doi: 10.1016/j.prro.2019.02.003.

PMID:
    30790716
    [PubMed - as supplied by publisher]
Related citations


Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial.
Henke LE, Olsen JR, Contreras JA, Curcuru A, DeWees TA, Green OL, Michalski J, Mutic S, Roach MC, Bradley JD, Parikh PJ, Kashani R, Robinson CG
Adv Radiat Oncol. 2019 Jan-Mar; 4(1)201-209. doi: 10.1016/j.adro.2018.10.003.

PMID:
    30706029
    [PubMed]
Related citations


Stereotactic Body Radiation Therapy for the Treatment of Primary Cardiac Angiosarcoma Causing Hemodynamic Instability.
Gabani P, Fischer-Valuck BW, Robinson CG, Wilson DB, Michalski JM
Pract Radiat Oncol. 2019 Jan; 9(1)5-8. doi: 10.1016/j.prro.2018.07.004.

PMID:
    30611463
    [PubMed - indexed for MEDLINE]
Related citations


Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia.
Robinson CG, Samson PP, Moore KMS, Hugo GD, Knutson N, Mutic S, Goddu SM, Lang A, Cooper DH, Faddis M, Noheria A, Smith TW, Woodard PK, Gropler RJ, Hallahan DE, Rudy Y, Cuculich PS
Circulation. 2019 Jan 15; 139(3)313-321. doi: 10.1161/CIRCULATIONAHA.118.038261.

PMID:
    30586734
    [PubMed - in process]
Related citations


Multi-Institutional Validation of a Knowledge-Based Planning Model for Patients Enrolled in RTOG 0617: Implications for Plan Quality Controls in Cooperative Group Trials.
Kavanaugh JA, Holler S, DeWees TA, Robinson CG, Bradley JD, Iyengar P, Higgins KA, Mutic S, Olsen LA
Pract Radiat Oncol. 2019 Mar; 9(2)e218-e227. doi: 10.1016/j.prro.2018.11.007.

PMID:
    30562615
    [PubMed - indexed for MEDLINE]
Related citations


Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer.
Videtic GM, Paulus R, Singh AK, Chang JY, Parker W, Olivier KR, Timmerman RD, Komaki RR, Urbanic JJ, Stephans KL, Yom SS, Robinson CG, Belani CP, Iyengar P, Ajlouni MI, Gopaul DD, Gomez Suescun JB, McGarry RC, Choy H, Bradley JD
Int J Radiat Oncol Biol Phys. 2019 Apr 1; 103(5)1077-1084. doi: 10.1016/j.ijrobp.2018.11.051.

PMID:
    30513377
    [PubMed - in process]
Related citations


Induction Radiation Therapy for Esophageal Cancer: Does Dose Affect Outcomes?
Semenkovich TR, Samson PP, Hudson JL, Subramanian M, Meyers BF, Kozower BD, Kreisel D, Patterson GA, Robinson CG, Bradley JD, Puri V
Ann Thorac Surg. 2019 Mar; 107(3)903-911. doi: 10.1016/j.athoracsur.2018.09.064.

PMID:
    30444988
    [PubMed - in process]
Related citations


Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy.
DeWees TA, Nikitas J, Rehman S, Bradley JD, Robinson CG, Roach MC
Pract Radiat Oncol. 2019 Jan; 9(1)e83-e89. doi: 10.1016/j.prro.2018.09.001.

PMID:
    30244094
    [PubMed - indexed for MEDLINE]
Related citations


Successful Treatment of Lichen Amyloidosis With Trichloroacetic Acid Peels.
Robinson CG, Jahan-Tigh RR
Dermatol Surg. 2018 Sep 17; doi: 10.1097/DSS.0000000000001661.

PMID:
    30234656
    [PubMed - as supplied by publisher]
Related citations


Optimizing radiation dose and fractionation for the definitive treatment of locally advanced non-small cell lung cancer.
Roach MC, Bradley JD, Robinson CG
J Thorac Dis. 2018 Aug; 10(Suppl 21)S2465-S2473. doi: 10.21037/jtd.2018.01.153.

PMID:
    30206492
    [PubMed]
Related citations


Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): A 4.5-Year Clinical Experience.
Henke LE, Contreras JA, Green OL, Cai B, Kim H, Roach MC, Olsen JR, Fischer-Valuck B, Mullen DF, Kashani R, Thomas MA, Huang J, Zoberi I, Yang D, Rodriguez V, Bradley JD, Robinson CG, Parikh P, Mutic S, Michalski J
Clin Oncol (R Coll Radiol). 2018 Nov; 30(11)720-727. doi: 10.1016/j.clon.2018.08.010.

PMID:
    30197095
    [PubMed - in process]
Related citations


Coccidioidomycosis in Nonhuman Primates: Pathologic and Clinical Findings.
Koistinen K, Mullaney L, Bell T, Zaki S, Nalca A, Frick O, Livingston V, Robinson CG, Estep JS, Batey KL, Dick EJ Jr, Owston MA
Vet Pathol. 2018 Nov; 55(6)905-915. doi: 10.1177/0300985818787306.

PMID:
    30071801
    [PubMed - indexed for MEDLINE]
Related citations


Stereotactic Body Radiation Therapy for Central Early-Stage NSCLC: Results of a Prospective Phase I/II Trial.
Roach MC, Robinson CG, DeWees TA, Ganachaud J, Przybysz D, Drzymala R, Rehman S, Kashani R, Bradley JD
J Thorac Oncol. 2018 Nov; 13(11)1727-1732. doi: 10.1016/j.jtho.2018.07.017.

PMID:
    30056162
    [PubMed - in process]
Related citations


A Complete Electron Microscopy Volume of the Brain of Adult Drosophila melanogaster.
Zheng Z, Lauritzen JS, Perlman E, Robinson CG, Nichols M, Milkie D, Torrens O, Price J, Fisher CB, Sharifi N, Calle-Schuler SA, Kmecova L, Ali IJ, Karsh B, Trautman ET, Bogovic JA, Hanslovsky P, Jefferis GSXE, Kazhdan M, Khairy K, Saalfeld S, Fetter RD, Bock DD
Cell. 2018 Jul 26; 174(3)730-743.e22. doi: 10.1016/j.cell.2018.06.019.

PMID:
    30033368
    [PubMed - indexed for MEDLINE]
Related citations


Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes.
Gabani P, Fischer-Valuck BW, Johanns TM, Hernandez-Aya LF, Keller JW, Rich KM, Kim AH, Dunn GP, Robinson CG, Chicoine MR, Huang J, Abraham CD
Radiother Oncol. 2018 Aug; 128(2)266-273. doi: 10.1016/j.radonc.2018.06.017.

PMID:
    29960685
    [PubMed - indexed for MEDLINE]
Related citations


In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
Henke LE, Kashani R, Hilliard J, DeWees TA, Curcuru A, Przybysz D, Green O, Robinson CG, Bradley JD
Int J Radiat Oncol Biol Phys. 2018 Nov 15; 102(4)987-995. doi: 10.1016/j.ijrobp.2018.06.022.

PMID:
    29953910
    [PubMed - in process]
Related citations


Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial.
Timmerman RD, Paulus R, Pass HI, Gore EM, Edelman MJ, Galvin J, Straube WL, Nedzi LA, McGarry RC, Robinson CG, Schiff PB, Chang G, Loo BW Jr, Bradley JD, Choy H
JAMA Oncol. 2018 Sep 1; 4(9)1263-1266. doi: 10.1001/jamaoncol.2018.1251.

PMID:
    29852037
    [PubMed - in process]
Related citations


First clinical implementation of real-time, real anatomy tracking and radiation beam control.
Green OL, Rankine LJ, Cai B, Curcuru A, Kashani R, Rodriguez V, Li HH, Parikh PJ, Robinson CG, Olsen JR, Mutic S, Goddu SM, Santanam L
Med Phys. 2018 May 28; doi: 10.1002/mp.13002.

PMID:
    29807390
    [PubMed - as supplied by publisher]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2017:

Company Name: Radialogica

Royalties:

Equity: Yes

Consulting/Advisory Board:

Speaker Fees:

Reporting Date: May 01, 2018


Company Name: Varian

Royalties:

Equity: No

Consulting/Advisory Board: $1 - $9,999

Speaker Fees: $20,000 - $39,999

Reporting Date: May 01, 2018